Anne H. Larsson - Publications

Reliability and validity of visual analysis of [ 18 F]FE-PE2I PET/CT in early Parkinsonian disease.

Journal: Nuclear medicine communications

Published: March 02, 2023

VNTR polymorphism in the SLC6A3 gene does not influence dopamine transporter availability measured by [18F]FE-PE2I PET or [123I]FP-Cit SPECT.

Journal: Nuclear medicine communications

Published: December 15, 2021

Improved PET/MRI attenuation correction in the pelvic region using a statistical decomposition method on T2-weighted images.

Journal: EJNMMI physics

Published: June 12, 2020

Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECT-a clinical comparison.

Journal: EJNMMI research

Published: August 20, 2018

Whole-Body Biodistribution and Dosimetry of the Dopamine Transporter Radioligand 18F-FE-PE2I in Human Subjects.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: June 07, 2017

Effect of gradient field nonlinearity distortions in MRI-based attenuation maps for PET reconstruction.

Journal: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)

Published: July 14, 2016

PETSTEP: Generation of synthetic PET lesions for fast evaluation of segmentation methods.

Journal: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)

Published: May 26, 2015